HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shusaku Mizukami Selected Research

Indicators and Reagents (Reagents)

5/2012Differential MyD88/IRAK4 requirements for cross-priming and tumor rejection induced by heat shock protein 70-model antigen fusion protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shusaku Mizukami Research Topics

Disease

6Infections
03/2023 - 01/2018
6Neoplasms (Cancer)
02/2015 - 05/2008
5Malaria
01/2023 - 12/2017
4Dengue (Dengue Fever)
04/2021 - 02/2016
2Zika Virus Infection
03/2022 - 01/2021
2Severe Dengue
03/2019 - 02/2016
2Persistent Infection
01/2019 - 01/2014
1Chagas Disease (American Trypanosomiasis)
03/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1COVID-19
07/2022
1Convalescence
01/2020
1Shock
02/2016
1Schistosomiasis japonica
08/2015
1Schistosomiasis (Bilharziasis)
08/2015
1Type 2 Diabetes Mellitus (MODY)
02/2015
1Virus Diseases (Viral Diseases)
12/2009
1Experimental Melanoma
05/2008

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2023 - 05/2008
5VaccinesIBA
01/2023 - 05/2008
5CytokinesIBA
04/2021 - 01/2014
4AntigensIBA
02/2015 - 01/2012
3Antimalarials (Antimalarial Agents)IBA
06/2021 - 12/2017
3Interleukin-17 (Interleukin 17)IBA
04/2021 - 01/2019
2coptisineIBA
03/2023 - 06/2020
2Messenger RNA (mRNA)IBA
01/2023 - 01/2023
2PF-429242IBA
03/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
03/2019 - 02/2016
2Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2012 - 05/2008
1NifurtimoxIBA
03/2023
1benzonidazole (benznidazole)IBA
03/2023
1CholesterolIBA
01/2023
1ThioureaIBA
01/2023
1Lipid NanoparticlesIBA
01/2023
1TeaIBA
07/2022
1glabridinIBA
03/2022
1Antiviral Agents (Antivirals)IBA
03/2022
1baicalinIBA
03/2022
1hemozoinIBA
06/2021
1Interleukin-8 (Interleukin 8)IBA
04/2021
1Interleukin-4 (Interleukin 4)IBA
04/2021
1Interleukin-10 (Interleukin 10)IBA
04/2021
1Interleukin-6 (Interleukin 6)IBA
04/2021
1Chloroquine (Aralen)FDA LinkGeneric
06/2020
1InterferonsIBA
01/2020
1Interleukin-5 (Interleukin 5)IBA
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
03/2019
1Chymases (Chymase)IBA
09/2018
1Immunoglobulin E (IgE)IBA
09/2018
1HLA-A Antigens (HLA-A)IBA
01/2018
1Antithrombin IIIIBA
02/2016
1Glutathione Transferase (Glutathione S-Transferase)IBA
08/2015
1DNA VaccinesIBA
08/2015
1AMP-Activated Protein KinasesIBA
02/2015
1Metformin (Glucophage)FDA LinkGeneric
02/2015
1dorsomorphinIBA
02/2015
1Cancer VaccinesIBA
01/2014
1OvalbuminIBA
05/2012
1Indicators and Reagents (Reagents)IBA
05/2012
1Histocompatibility Antigens Class IIBA
12/2009
1LigandsIBA
12/2009
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2008
1EpitopesIBA
05/2008
1incomplete Freund's adjuvantIBA
05/2008
1Peptides (Polypeptides)IBA
05/2008

Therapy/Procedure

1Intraperitoneal Injections
03/2023